A carregar...
Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study
BACKGROUND: This study evaluated the efficacy, safety and tolerability of the novel inhaled phosphodiesterase-4 inhibitor CHF6001 added-on to formoterol in patients with chronic obstructive pulmonary disease (COPD). METHODS: Randomised, double-blind, placebo- and active-controlled, parallel-group st...
Na minha lista:
| Publicado no: | Respir Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7510119/ https://ncbi.nlm.nih.gov/pubmed/32962709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01512-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|